Connection
Theodore Karrison to Fibroblast Growth Factors
This is a "connection" page, showing publications Theodore Karrison has written about Fibroblast Growth Factors.
|
|
Connection Strength |
|
 |
|
 |
|
0.016 |
|
|
|
-
Stadler WM, Cao D, Vogelzang NJ, Ryan CW, Hoving K, Wright R, Karrison T, Vokes EE. A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer. Clin Cancer Res. 2004 May 15; 10(10):3365-70.
Score: 0.016